Total submissions: 3
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Myriad Genetics, |
RCV003643662 | SCV006095950 | benign | Breast-ovarian cancer, familial, susceptibility to, 4 | 2025-02-25 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
| Ambry Genetics | RCV004950521 | SCV005485307 | likely benign | Hereditary cancer-predisposing syndrome | 2024-06-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
| Labcorp Genetics |
RCV003643662 | SCV004410774 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 4 | 2023-02-08 | criteria provided, single submitter | clinical testing |